OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review
Chao Wang, Yujing Zhang, Tingting Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127440-127440
Closed Access | Times Cited: 7
Chao Wang, Yujing Zhang, Tingting Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127440-127440
Closed Access | Times Cited: 7
Showing 7 citing articles:
Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy(2006-present)
Yufeng An, Xinya Lv, Shidi Xu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117268-117268
Closed Access
Yufeng An, Xinya Lv, Shidi Xu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117268-117268
Closed Access
Therapeutic Insights of Indole Scaffold‐Based Compounds as Protein Kinase Inhibitors
Dina H. Dawood
ChemistrySelect (2025) Vol. 10, Iss. 5
Open Access
Dina H. Dawood
ChemistrySelect (2025) Vol. 10, Iss. 5
Open Access
Discovery of a prominent dual-target DDR1/EGFR inhibitor aimed DDR1/EGFR-positive NSCLC
Xuebao Wang, Ying Lu, Siyu Chen, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107500-107500
Closed Access | Times Cited: 3
Xuebao Wang, Ying Lu, Siyu Chen, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107500-107500
Closed Access | Times Cited: 3
Synthesis, characterization and biological research of novel 2-(quinoline-4-carbonyl)hydrazide-acrylamide hybrids as potential anticancer agents on MCF-7 breast carcinoma cells by targeting EGFR-TK
Hany M. Abd El‐Lateef, Duaa Bafail, Noura Hamdi Yousef Alhalees, et al.
RSC Advances (2024) Vol. 14, Iss. 32, pp. 23495-23504
Open Access | Times Cited: 2
Hany M. Abd El‐Lateef, Duaa Bafail, Noura Hamdi Yousef Alhalees, et al.
RSC Advances (2024) Vol. 14, Iss. 32, pp. 23495-23504
Open Access | Times Cited: 2
Integrating anoikis and ErbB signaling insights with machine learning and single-cell analysis for predicting prognosis and immune-targeted therapy outcomes in hepatocellular carcinoma
Huipeng Fang, Xingte Chen, Yaqi Zhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Huipeng Fang, Xingte Chen, Yaqi Zhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Aggressive and Metastatic Pituitary Neuroendocrine Tumors: Therapeutic Management and Off-Label Drug Use
Pedro Iglesias
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 116-116
Open Access | Times Cited: 2
Pedro Iglesias
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 116-116
Open Access | Times Cited: 2
Synthesis and Biological Evaluation of Novel Cationic Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivative for Epidermal Growth Factor Receptor Targeting
Sotiria Triantopoulou, Ioanna Roupa, Antonio Shegani, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1213-1213
Open Access
Sotiria Triantopoulou, Ioanna Roupa, Antonio Shegani, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1213-1213
Open Access
